Pierre Cordelier

8PUBLICATIONS
44CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSolid tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 10, 2026
SG33, a Vaccine Strain of Myxoma Virus with Oncolytic Potential, Exploits Macropinocytosis and Clathrin-Mediated Endocytosis for Entry into Pancreatic Cancer Cells.

Nikolaos Kontopoulos, Noémie Delenclos, Laetitia Ligat

|Aug 30, 2024
Cytidine deaminase-dependent mitochondrial biogenesis as a potential vulnerability in pancreatic cancer cells.

Audrey Frances, Audrey Lumeau, Nicolas Bery

|Jan 31, 2024
Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs.

Audrey Lumeau, Nicolas Bery, Audrey Francès

|Feb 11, 2023
Pancreatic Cancer in Chronic Pancreatitis: Pathogenesis and Diagnostic Approach.

Guillaume Le Cosquer, Charlotte Maulat, Barbara Bournet

|Dec 31, 2022
Pancreatic Cancer Cell and Gene Biotherapies: Past, Present, and Future.

Lorraine Quillien, Louis Buscail, Pierre Cordelier

|Sep 23, 2022
Upregulated Apelin Signaling in Pancreatic Cancer Activates Oncogenic Signaling Pathways to Promote Tumor Development.

Carline Chaves-Almagro, Johanna Auriau, Alizée Dortignac

Pageof 2

Frequent Collaborators

2 joint publications

Jerome Torrisani

2 joint publications

Audrey Francès

2 joint publications

Nicolas Bery

2 joint publications

Audrey Lumeau